Form D · Biotechnology
Cyclacel Pharmaceuticals, Inc.
Berkeley Heights, NJ · CIK 0001130166
Offering snapshot reported Mar 25, 2025 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 25, 2025 | Initial | $1,000,000 | No comparison | 4 | SEC filing |
| Feb 14, 2025 | Initial | Yet to sell | No comparison | 1 | SEC filing |
| Feb 14, 2025 | Initial | $0 | No comparison | 1 | SEC filing |
| Nov 26, 2024 | Initial | $2,062,112 | No comparison | 1 | SEC filing |
| May 17, 2024 | Initial | $8,000,000 | No comparison | 1 | SEC filing |
| Jan 4, 2021 | Initial | $7,000,000 | No comparison | 1 | SEC filing |
| May 1, 2012 | Initial | $3,036,000 | No comparison | 7 | SEC filing |
| Oct 21, 2010 | Initial | $15,200,226 | No comparison | 20 | SEC filing |
| Dec 31, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 30, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-542076
Company sold $1,000,000 of convertible Series E Preferred Stock
Source: Form D, filed Mar 25, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nicholas Bacopoulos | Director |
| John Banham | Director |
| Samuel Barker | Director |
| Avraham Ben Tzvi | Director |
| Judy Chiao | Executive |
| Kwang Fock Chong | Director |
| Kenneth Ferguson | Director |
| Christopher Henney | Director |
| Gregory T. Hradsky | Director |
| Mark H. Kirschbaum | Executive |
| David Lazar | Executive |
| Paul Mc Barron | Director |
| David Natan | Director |
| Spiro Rombotis | Director |
| Brian Schwartz | Director |
| Lloyd Sems | Director |
| Kiu Cu Seng | Executive |
| Robert J. Speigel | Director |
| Robert Spiegel | Director |
| Daniel K. Spiegelman | Director |
| David U'prichard | Director |
| Karin Walker | Director |
| Datuk Dr. Doris Wong Sing Ee | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
200 Connell Drive, Suite 1500
Berkeley Heights, NJ, 07922
Berkeley Heights, NJ, 07922